Go Pro

Inhibikase Therapeutics (IKT) Institutional Ownership

Inhibikase Therapeutics logo
$2.40 +0.05 (+2.13%)
As of 02:15 PM Eastern

Institutional Ownership Changes (13F Filings) for Inhibikase Therapeutics (NASDAQ:IKT)

Current
Institutional Ownership
Percentage
3.81%
Number of
Institutional Buyers
(last 12 months)
34
Total
Institutional Inflows
(last 12 months)
$68.56M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$8.64M
Get IKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inhibikase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IKT Institutional Buying and Selling by Quarter

Inhibikase Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/6/2026 Bank of New York Mellon Corp303,126$615K0.0%N/A0.230%
6/4/2026 Seven Fleet Capital Management LP325,600$547K0.2%-39.0%0.247%
5/29/2026 Perceptive Advisors LLC2,315,000$3.89M0.1%-57.3%1.753%
5/19/2026 Bank of America Corp DE322,704$542K0.0%+595.3%0.244%
5/19/2026 Ally Bridge Group NY LLC1,325,000$2.23M1.8%N/A1.004%
5/18/2026 ADAR1 Capital Management LLC6,606,572$11.10M0.7%-18.1%5.004%
5/16/2026 The Manufacturers Life Insurance Company28,773$48K0.0%N/A0.022%
5/16/2026 SummitTX Capital L.P.1,524,536$2.56M0.1%N/A1.155%
5/16/2026 Kalehua Capital Management LLC3,821,890$6.42M4.6%+118.4%2.895%
5/15/2026 Rangeley Capital LLC220,000$370K0.3%N/A0.167%
5/14/2026 Renaissance Technologies LLC16,500$28K0.0%N/A0.012%
5/14/2026 Sei Investments Co.47,962$81K0.0%N/A0.036%
5/5/2026 Bank of New York Mellon Corp213,208$358K0.0%+55.1%0.161%
4/16/2026 SG Americas Securities LLC15,480$26K0.0%N/A0.012%
2/26/2026 Seven Fleet Capital Management LP533,648$1.09M0.8%N/A0.710%
2/23/2026 Virtu Financial LLC22,869$47K0.0%+70.1%0.030%
2/18/2026 ADAR1 Capital Management LLC8,063,949$16.53M1.2%+53.7%10.727%
2/18/2026 XTX Topco Ltd20,298$42K0.0%N/A0.027%
2/18/2026 Squadron Capital Management LLC4,225,000$8.66M3.7%N/A5.620%
2/18/2026 Millennium Management LLC169,850$348K0.0%N/A0.226%
2/17/2026 ADAR1 Capital Management LLC8,063,949$16.53M1.2%+53.7%10.727%
2/17/2026 Integral Health Asset Management LLC1,750,000$3.59M0.2%N/A2.328%
2/17/2026 Persistent Asset Partners Ltd93,430$192K0.1%N/A0.124%
2/16/2026 Spruce Street Capital LP3,581,603$7.34M2.4%N/A4.764%
2/16/2026 Sands Capital Alternatives LLC13,018,965$26.69M5.1%+18.9%17.318%
2/16/2026 Barclays PLC94,795$194K0.0%+10.8%0.126%
2/13/2026 Nantahala Capital Management LLC3,929,292$8.06M0.3%+79.4%5.227%
2/13/2026 Kalehua Capital Management LLC1,750,000$3.59M3.3%N/A2.328%
2/13/2026 Exome Asset Management LLC600,000$1.23M0.6%N/A0.798%
2/13/2026 Siren L.L.C.5,850,000$11.99M0.4%N/A7.782%
2/13/2026 State Street Corp554,849$1.14M0.0%+9.3%0.738%
2/13/2026 Wells Fargo & Company MN67,833$139K0.0%+48.3%0.090%
2/12/2026 Jane Street Group LLC116,003$238K0.0%N/A0.154%
2/11/2026 Deutsche Bank AG54,909$113K0.0%-31.8%0.073%
2/10/2026 Goldman Sachs Group Inc.85,267$175K0.0%+694.3%0.113%
2/9/2026 Geode Capital Management LLC1,128,239$2.31M0.0%+1.4%1.501%
1/29/2026 Sanctuary Advisors LLC12,539$26K0.0%N/A0.017%
1/1/2026 JPMorgan Chase & Co.49,937$81K0.0%+74.7%0.066%
11/17/2025 Susquehanna International Group LLP45,605$74K0.0%-88.1%0.061%
11/17/2025 Citadel Advisors LLC71,670$116K0.0%N/A0.096%
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
11/14/2025 ADAR1 Capital Management LLC5,247,603$8.50M0.8%+2.5%7.042%
11/13/2025 BNP Paribas Financial Markets15,640$25K0.0%+70.3%0.021%
11/7/2025Vanguard Group Inc.3,273,339$5.30M0.0%+1.5%4.393%
11/7/2025 JPMorgan Chase & Co.49,937$81K0.0%+74.7%0.067%
11/3/2025 New York State Common Retirement Fund47,900$78K0.0%-21.1%0.064%
8/15/2025 Perceptive Advisors LLC5,432,293$10.59M0.9%-8.3%7.307%
8/15/2025 Bank of America Corp DE19,216$37K0.0%-57.3%0.026%
8/14/2025 Commodore Capital LP5,397,488$10.53M0.7%+1.0%7.260%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.33,023$64K0.0%N/A0.044%
8/13/2025 Stonepine Capital Management LLC733,793$1.43M1.4%-19.8%0.987%
8/13/2025 Invesco Ltd.30,712$60K0.0%N/A0.041%
8/13/2025 New York State Common Retirement Fund60,700$118K0.0%N/A0.082%
8/12/2025 JPMorgan Chase & Co.28,579$56K0.0%N/A0.038%
8/8/2025 Intech Investment Management LLC31,406$61K0.0%N/A0.042%
8/8/2025 Police & Firemen s Retirement System of New Jersey17,638$34K0.0%N/A0.024%
8/8/2025 Geode Capital Management LLC1,066,700$2.08M0.0%+228.5%1.435%
6/27/2025 Goldman Sachs Group Inc.166,025$364K0.0%+277.7%0.223%
5/19/2025Jane Street Group LLC116,249$255K0.0%N/A0.156%
5/16/2025Goldman Sachs Group Inc.166,025$364K0.0%+277.7%0.223%
5/16/2025ADAR1 Capital Management LLC5,122,105$11.22M2.1%+0.4%6.890%
5/14/2025Stonepine Capital Management LLC914,973$2.00M1.9%-19.2%1.231%
5/9/2025Blair William & Co. IL155,953$342K0.0%+15.6%0.210%
5/6/2025Y Intercept Hong Kong Ltd26,775$59K0.0%N/A0.036%
2/27/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%
2/18/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%
2/17/2025Soleus Capital Management L.P.6,325,000$20.56M1.3%N/A9.119%
2/17/2025Squarepoint Ops LLC28,411$92K0.0%N/A0.041%
2/17/2025Stonepine Capital Management LLC1,132,388$3.68M3.0%N/A1.633%
2/17/2025OMERS ADMINISTRATION Corp54,600$177K0.0%N/A0.079%
2/17/2025Millennium Management LLC142,209$462K0.0%N/A0.205%
2/17/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%
2/17/2025Fairmount Funds Management LLC6,125,000$19.91M2.0%N/A8.831%
2/17/2025Blackstone Inc.2,070,684$6.73M0.0%N/A2.985%
2/17/2025Caxton Corp16,393$53K0.3%N/A0.024%
2/14/2025Nantahala Capital Management LLC2,190,000$7.12M0.3%N/A3.157%
2/14/2025Northern Trust Corp64,011$208K0.0%N/A0.092%
2/14/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%
2/14/2025Stifel Financial Corp13,129$43K0.0%N/A0.019%
2/13/2025Barclays PLC84,000$273K0.0%N/A0.121%
2/13/2025ADAR1 Capital Management LLC5,103,005$16.59M3.3%N/A7.357%
2/12/2025Geode Capital Management LLC322,878$1.05M0.0%+544.9%0.466%
2/12/2025Blair William & Co. IL134,953$439K0.0%+7.0%0.195%
8/15/2024Armistice Capital LLC589,575$713K0.0%N/A8.170%
11/15/2023Armistice Capital LLC186,046$259K0.0%-62.5%3.477%
9/21/2023Barclays PLC11,455$41K0.0%N/A0.214%
8/8/2023Hamilton Lane Advisors LLC13,802$50K0.0%-83.3%0.266%
5/2/2023Hamilton Lane Advisors LLC82,817$54K0.0%N/A0.286%
2/10/2023Blair William & Co. IL229,000$114K0.0%+27.9%0.817%
7/12/2022Koshinski Asset Management Inc.65,377$49K0.0%N/A0.259%


IKT Institutional Ownership - Frequently Asked Questions

During the previous two years, 56 institutional investors and hedge funds held shares of Inhibikase Therapeutics. The most heavily invested institutionals were Sands Capital Alternatives LLC ($26.69M), Soleus Capital Management L.P. ($20.56M), Fairmount Funds Management LLC ($19.91M), Siren L.L.C. ($11.99M), ADAR1 Capital Management LLC ($11.10M), Commodore Capital LP ($10.53M), and Squadron Capital Management LLC ($8.66M).Learn more on Inhibikase Therapeutics' institutional investors.

3.81% of Inhibikase Therapeutics' stock is owned by institutional investors. Learn more on IKT's institutional investor holdings.

Of the 53 institutional investors that purchased Inhibikase Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($10.88M), Soleus Capital Management L.P. ($6.33M), Fairmount Funds Management LLC ($6.13M), Siren L.L.C. ($5.85M), Squadron Capital Management LLC ($4.23M), Nantahala Capital Management LLC ($3.93M), and Kalehua Capital Management LLC ($3.82M).

Institutional investors have bought a total of 34,521,939 shares in the last 24 months. This purchase volume represents approximately $68.56M in transactions.

The following institutional investors have sold Inhibikase Therapeutics stock in the last 24 months: Perceptive Advisors LLC ($3.11M), ADAR1 Capital Management LLC ($1.46M), Susquehanna International Group LLP ($337.47K), Seven Fleet Capital Management LP ($208.05K), Deutsche Bank AG ($25.59K), and New York State Common Retirement Fund ($12.80K).

Institutional investors have sold a total of 5,147,846 shares in the last 24 months. This volume of shares sold represents approximately $8.64M in transactions.



Institutional ownership data for NASDAQ:IKT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners